David W. Bamberger, PAC   OFFICE LOCATION Cardiology Research Associates (2001-Present) Cardiology Physicians, PA (2001-Present) 873 Sterthaus Ave. Suite 302 Ormond Beach, FL 32174   TELEPHONE: Office: 386-677-6672 & 386-677-5351 Fax: (386) 677-0541

EDUCATION

 

MEDICAL LICENSURE

Pennsylvania, Physician Assistant (MA-001292-L)
Florida, Physician Assistant (PA-2661)

 

CERTIFICATIONS

NCCPA (1020851)
ACLS Provider
PALS

 

HOSPITAL AFFILIATIONS

 

PROFESSIONAL EXPERIENCE

 

RESEARCH ACTIVITY

 

ATRIAL FIBRILLATION/ATRIAL FLUTTER

Sub-Investigator in a Clinical Trial for Sanofi-Aventis. Prevention of Cardiovascular Hospitalization or Death from any cause of Atrial Fibrillation or Atrial Flutter.

Sub-Investigator in a Clinical Trial for Boehringer Ingelheim Pharmaceuticals, Inc. Prevention of Stroke and Systemic Embolism with Non-Valvular Atrial Fibrillation.

Sub-Investigator in a Clinical Trial with Sanofi-Synthelabo. Evaluation of Clopidogrel plus Aspirin with Factorial Evaluation of Irbestan, for the Prevention of Vascular Events in subjects with Atrial Fibrillation

 

CORONARY ARTERY DISEASE

Sub-Investigator in a Clinical Trial for Astra-Zeneca Pharmaceuticals LP. Primary prevention of Cardiovascular Events among subjects with Low levels of Ldl Cholesterol and Elevated levels of C-Reactive Protein.

 

LEFT VENTRICULAR HYPERTROPHY

Sub-Investigator in a Clinical Trial for GlaxoSmithKline. Comparing the Effects of Carvedilol Modified Release Formulation and Atenolol in Combination with and Compared to an Antiotensin Converting Enzyme Inhibitor on Left Ventricular Mass Regression in Hypertensive subjects with LVH.

Sub-Investigator in a Clinical Trial for Novartis Pharmceuticals Corporation. Evaluate the Efficacy of Lotrel and Benazepril/Hydrochlorothiazide in the Regression of LVH by MRI in subjects with High risk Hypertension.

Sub-Investigator in a Clinical Trial with Sanofi-Synthelabo. Evaluation of Clopidogrel plus Aspirin with Factorial Evaluation of Irbestan, for the Prevention of Vascular Events in subjects with Atrial Fibrillation.

 

 

 

 

 

Home | About Us | Office Locations | Procedures
Physicians | Prevention | Contact Us

 

 

The material provided on this site is for general information purposes only.
It is not intended to be used as medical advice and does not substitute
for proper consultation with trained medical personnel.